Biotech · Private company
Crystalys Therapeutics
Track this companyFree. Adds Crystalys Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- AllopurinolPhase 3 · GoutClinicalTrials.gov · fetched Nov 12, 2026
- AllopurinolPhase 3 · Tophaceous GoutClinicalTrials.gov · fetched Nov 12, 2026
- DotinuradPhase 3 · GoutClinicalTrials.gov · fetched Nov 12, 2026
- DotinuradPhase 3 · Tophaceous GoutClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout ParticipantsPHASE2 · RECRUITING · started May 8, 2026ClinicalTrials.gov NCT07535034 · fetched Nov 12, 2026
- A Study of Dotinurad Versus Allopurinol in Tophaceous GoutPHASE3 · RECRUITING · started Aug 4, 2025ClinicalTrials.gov NCT07089888 · fetched Nov 12, 2026
- A Study of Dotinurad Versus Allopurinol in Participants With GoutPHASE3 · RECRUITING · started Aug 1, 2025ClinicalTrials.gov NCT07089875 · fetched Nov 12, 2026